BL
BBIO icon

BFSG LLC’s BridgeBio Pharma BBIO Stock Holding History

BFSG LLC’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.9K Hold
240
– – ﹤0.01% 520
2026
Q1 		$17.8K Hold
240
– – ﹤0.01% 510
2025
Q4 		$18.4K Hold
240
– – ﹤0.01% 490
2025
Q3 		$12.5K Hold
240
– – ﹤0.01% 524
2025
Q2 		$10.4K Hold
240
– – ﹤0.01% 507
2025
Q1 		$8.3K Sell
240
-1,000
-81% -$33.7K ﹤0.01% 518
2024
Q4 		$34K Hold
1,240
– – ﹤0.01% 410
2024
Q3 		$31.6K Hold
1,240
– – ﹤0.01% 413
2024
Q2 		$31.4K Buy
1,240
+790
+176% +$21.6K ﹤0.01% 394
2024
Q1 		$13.9K Buy
450
+300
+200% +$10.2K ﹤0.01% 466
2023
Q4 		$6.06K Buy
+150
New +$4.5K ﹤0.01% 490

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

BFSG LLC's BBIO Position: Q2 2026 in Review

BFSG LLC held its BridgeBio Pharma (BBIO) position steady in Q2 2026 at 240 shares worth $17.9K. The position accounts for ﹤0.01% of the portfolio, ranked #520.

BFSG LLC first reported a position in BBIO in Q4 2023 and has held it in 11 quarters since. The position peaked at $34K in Q4 2024. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • BFSG LLC held 240 shares of BridgeBio Pharma worth $17.9K as of Q2 2026.
  • BFSG LLC left its BridgeBio Pharma share count unchanged in Q2 2026.
  • BridgeBio Pharma made up ﹤0.01% of BFSG LLC's portfolio in Q2 2026, its #520 holding.
  • BFSG LLC first reported a position in BridgeBio Pharma in Q4 2023 and has held it in 11 quarters since.
  • BFSG LLC's BridgeBio Pharma position peaked at $34K in Q4 2024.
  • 474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on BFSG LLC's 13F filing for Q2 2026, filed 20 Jul 2026.